432 research outputs found

    Alpha One Antitrypsin Deficiency: A Pulmonary Genetic Disorder

    Get PDF

    Chapter 5 Technological accretion in diagnostics

    Get PDF
    This book brings together a collection of empirical case studies featuring a wide spectrum of medical innovation. While there is no unique pathway to successful medical innovation, recurring and distinctive features can be observed across different areas of clinical practice. This book examines why medical practice develops so unevenly across and within areas of disease, and how this relates to the underlying conditions of innovation across areas of practice. The contributions contained in this volume adopt a dynamic perspective on medical innovation based on the notion that scientific understanding, technology and clinical practice co-evolve along the co-ordinated search for solutions to medical problems. The chapters follow an historical approach to emphasise that the advancement of medical know-how is a contested, nuanced process, and that it involves a variety of knowledge bases whose evolutionary paths are rooted in the contexts in which they emerge. This book will be of interest to researchers and practitioners concerned with medical innovation, management studies and the economics of innovation. Chapter 5 of this book is freely available as a downloadable Open Access PDF under a Creative Commons Attribution-Non Commercial-No Derivatives 3.0 license. https://s3-us-west-2.amazonaws.com/tandfbis/rt-files/docs/Open+Access+Chapters/9781138860346_oachapter5.pd

    The emergence of molecular biology in the diagnosis of cervical cancer: A network perspective

    Get PDF
    Trabajo presentado a la Atlanta Conference on Science and Innovation Policy, celebrada en Atlanta (US) del 17 al 19 de septiembre de 2015.Cytology-base technologies have been extensively used for decades to diagnose cervical cancer in women despite the large number of false negative cases those may report. The rise of molecular biology, since mid-1980s, has spurred the emergence of novel diagnostic technologies, which have significantly changed both the research landscape and clinical practices around cervical cancer. Within this context, the present paper examines how different institutional groups of actors (research and higher education, governmental, hospital and care, industrial, and non-governmental organisations) have contributed to the emergence of molecular biology from an inter-organisational network lens (co-authorship data of publications). To do so, we analyse the patterns of network interactions among different institutional groups involved in the emerge process. We specifically examine the formation of ties (dyads) within and between groups as well as the extent to which organisational actors operate in di↵erent brokerage positions (triads) over the emergence process. The analysis is based on a sample of scientific articles published over more than 30 years in the diagnosis domain of cervical cancer research. Findings provide evidence that the process of tie formation as well as the brokerage activity follow different patterns according to the considered institutional group. The process of tie formation and brokerage activity also evolve over emergence.N

    Are there three main subgroups within the patellofemoral pain population? A detailed characterisation study of 127 patients to help develop targeted Intervention (TIPPs)

    Get PDF
    • Background Current multimodal approaches for the management of non-specific patellofemoral pain are not optimal, however, targeted intervention for subgroups could improve patient outcomes. This study explores whether subgrouping of non-specific patellofemoral pain patients, using a series of low cost simple clinical tests, is possible. • Method The exclusivity and clinical importance of potential subgroups was assessed by applying à priori test thresholds (1 SD) from seven clinical tests in a sample of adult patients with non-specific patellofemoral pain. Hierarchical clustering and latent profile analysis, were used to gain additional insights into subgroups using data from the same clinical tests. • Results One hundred and thirty participants were recruited, 127 had complete data: 84 (66%) female, mean age 26 years (SD 5.7) and mean BMI 25.4 (SD 5.83), median (IQR) time between onset of pain and assessment was 24 (7-60) months. Potential subgroups defined by the à priori test thresholds were not mutually exclusive and patients frequently fell into multiple subgroups. Using hierarchical clustering and latent profile analysis three subgroups were identified using 6 of the 7 clinical tests. These subgroups were given the following nomenclature: (i) ‘strong’, (ii) ‘weak and tighter’, and (iii) ‘weak and pronated foot’. • Conclusions We conclude that three subgroups of patellofemoral patients may exist based on the results of six clinical tests which are feasible to perform in routine clinical practice. Further research is needed to validate these findings in other datasets and, if supported by external validation, to see if targeted interventions for these subgroups improve patient outcomes
    • …
    corecore